Data on long-term actual survival in patients with surgically resected pancreatic ductal adenocarcinoma (PDAC) are limited. The aim of this study was to evaluate the actual 5-year disease-specific survival (DSS) and post-recurrence survival (PRS) in patients who underwent pancreatectomy for PDAC.
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival / Belfiori, G., Crippa, S., Aleotti, F., Pagnanelli, M., Tamburrino, D., Gasparini, G., Partelli, S., Andreasi, V., Rubini, C., Zamboni, G., Falconi, M.. - In: ANNALS OF SURGICAL ONCOLOGY. - ISSN 1534-4681. - 28:13(2021), pp. 8249-8260. [10.1245/s10434-021-10401-7]
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival
Belfiori, Giulio;Crippa, Stefano;Francesca, Aleotti;Pagnanelli, Michele;Gasparini, Giulia;Partelli, Stefano;Andreasi, Valentina;Falconi, Massimo
2021-01-01
Abstract
Data on long-term actual survival in patients with surgically resected pancreatic ductal adenocarcinoma (PDAC) are limited. The aim of this study was to evaluate the actual 5-year disease-specific survival (DSS) and post-recurrence survival (PRS) in patients who underwent pancreatectomy for PDAC.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
